MONICA KOST: Open Payments
NPI 1205336740 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $221 |
| Axsome Therapeutics, Inc. | 2 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| ABBVIE INC. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $19 |
Products named: FANAPT, Auvelity, CAPLYTA, HETLIOZ, REXULTI, VRAYLAR, INVEGA SUSTENNA, Kimyrsa.
Industry payments across IA — which companies pay providers there.
